Glenmark initiates a multi-country phase 3 clinical trial for Envafolimab

Pharmaceutical Commerce: October 2025 Interactive Digital Edition

DRRA25 minutes ago 0

What Schreiner MediPharm’s RFID-Embedded Label Launch at CPHI Frankfurt Means for Manufacturing

DRRA2 hours ago 0

FDA Approves Johnson & Johnson’s Simponi for Pediatric Ulcerative Colitis

DRRA3 hours ago 0

Venture firms pour $101M into a biotech using the brain to fix the immune system

DRRA3 hours ago 0